Kelley Mack, who portrayed Addy in Season 9 of The Walking Dead, has died at the age of 33. Her family announced that Mack ...

Day One Biopharmaceuticals poised for growth with OJEMDA success and FIREFLY-2 catalysts. See here to know why we are bullish ...

Kelley Mack’s death on Aug. 2 at age 33 was "very unexpected," her rep tells PEOPLE. The 'Walking Dead' actress was still ...

Kelley Mack, an actor who starred in "The Walking Dead," died due to complications from the COVID-19 vaccine. Actor Kelley ...

Modeyso is the first drug to treat patients with diffuse midline glioma with an H3 K27M mutation, an ultra-rare and aggressive brain tumor.

Kelley Mack of 'The Walking Dead' passed away at 33 following her battle with glioma. Learn about her diagnosis symptoms and ...

The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of diffuse midline glioma harboring an ...

Actress Kelley Mack, best known for her role as Addy on The Walking Dead, has passed away at just 33 years old. Her family ...

The FDA granted accelerated approval to dordaviprone for the treatment of patients aged 1 year and older with recurrent diffuse midline glioma who harbor the H3 K27M mutation with progressive disease ...

In a combined analysis of patients from five open-label trials, 22 percent responded to the protease activator, the first approved treatment for the rare disease.

Q2 2025 Earnings Call Transcript August 5, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...